Skip to content

Ingestion of Beta-alanine Effects in Well-trained Tennis Players

Ingestion of Beta-alanine Improves Neuromuscular Performance in Well-trained Tennis. A Randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05427409
Acronym
BETA_TENNIS
Enrollment
14
Registered
2022-06-22
Start date
2020-11-04
Completion date
2021-06-01
Last updated
2022-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Beta-alanine, Placebo

Brief summary

Beta-alanine is considered as ergogenic aids with good to strong evidence for improving sports performance in specific sports context scenarios. However, most of the studies has been realized in endurance, with limited evidence in intermittent sports, especially in racket sports. Thus, the aim of this study was to explore the effects of 4-weeks ingestion of beta-alanine on neuromuscular performance in well-trained tennis players.

Detailed description

Fourteen tennis players (23.3 ±3.7 years) between 50-250 national tennis ranking participated in this study. Participants were randomly divided into two groups that realized a neuromuscular battery after beta-alanine (4.8 gr/daily during 4-weeks) or placebo (i.e., fructose) (4.8 grams/daily during 4-weeks). Before and after the supplementation period tennis performed a neuromuscular test battery in a tennis court consisted in different test such as; serve velocity, countermovement jump, isometric handgrip strength, 10-m sprint, modified 5-0-5 agility test and repeated sprint ability. After 48 h of the realization of neuromuscular test battery, tennis players performed VO2max consumption test (i.e., treadmill).

Interventions

In a randomized order, two groups (n=7) was randomly assigned to beta-alanine and placebo during a 4-weeks period

Sponsors

University of Seville
CollaboratorOTHER
University of Greenwich
CollaboratorOTHER
Universidad Francisco de Vitoria
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Well-trained tennis players, between 18-35 years old (50-200 between tennis ranking)

Exclusion criteria

* Suffering from any chronic pathology or an injury in the month prior to the investigation. * Intolerance to beta-alanine ingestion * Amateur tennis players.

Design outcomes

Primary

MeasureTime frameDescription
Repeated sprint ability test.4-weeksInfrared photocells system (Microgate, Italy)
VO2 max treadmill test4-weeksUsing VO2 max analyzer (Ergostik, Geratherm Respiratory, Ergostik, Geratherm, Germany)

Secondary

MeasureTime frameDescription
10m sprint4-weeksInfrared photocells system (Microgate, Italy)
Serve velocity4-weeksStroke velocity radar gun (Radar Pocket, South Korea)
Modified agility test 5-0-54-weeksInfrared photocells system (Microgate, Italy)
Isometric handgrip strength4-weeksHand held dynamometer (Takei, Japan)
Contermovement Jump4-weeksContact Jump (Chronojump, Spain)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026